Bank Julius Baer & Co’s BioTelemetry, Inc. BEAT Stock Holding History

Bank Julius Baer & Co’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-999	Closed	-$72K	–	925
2020 Q4	$72K	Sell	999 -503	-33%	-$26.3K	﹤0.01%	658
2020 Q3	$68K	Sell	1,502 -2	-0.1%	-$84	﹤0.01%	585
2020 Q2	$68K	Buy	+1,504	New	+$67.4K	﹤0.01%	547

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Bank Julius Baer & Co's BEAT Position: Q1 2021 in Review

Bank Julius Baer & Co sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 999 shares — an estimated $72K sold.

Bank Julius Baer & Co first reported a position in BEAT in Q2 2020 and held it in 3 quarters. The position peaked at $72K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Bank Julius Baer & Co reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Bank Julius Baer & Co sold 999 BioTelemetry, Inc. shares in Q1 2021, an estimated $72K.
Bank Julius Baer & Co first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 3 quarters.
Bank Julius Baer & Co's BioTelemetry, Inc. position peaked at $72K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.